Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.

---

Atıf İçin Kopyala

TAS F., AYKAN F., AYDINER A., Yasasever V., TOPUZ E.

American journal of clinical oncology, cilt.24, sa.2, ss.148-9, 2001 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 24 Sayı: 2
• Basım Tarihi: 2001
• Doi Numarası: 10.1097/00000421-200104000-00010
• Dergi Adı: American journal of clinical oncology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.148-9
• İstanbul Üniversitesi Adresli: Evet

Özet

In 35 patients with recurrent gastric cancer who had undergone curative gastrectomy, serum carcinoembryonic antigen (CEA) and CA 19-9 (carbohydrate antigen) rumor marker levels were investigated. At least one tumor marker was elevated in 24 (68.6%) patients. The levels of serum CA 19-9 and CEA markers were increased in 20 (57.1%,) and 12(34.3%) patients, respectively. This difference was not statistically significant. However, it may be important in terms of clinical practice.